N/A
N=417
The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19
COVID-19
Bottom Line
View on ClinicalTrials.gov: NCT04327674 ↗Enrolled (actual)
417
Serious AEs
100.0%
Results posted
Jun 2024
Primary outcome: Primary: Mechanical Ventilation — 21 Participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Aarhus
- Primary completion
- Jun 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mechanical Ventilation |
21 | — |
| SECONDARY FLUS Findings and Admission to Intensive Care. |
28 | — |
| SECONDARY SAR-CoV-2 PCR-test Result. |
227 | — |
Summary
COVID is a major health problem causing massive capacity problems at hospitals. Rapid and accurate diagnostic workflow is of paramount importance. Access to radiological diagnostics tools such as x-ray or computed tomography of the chest are limited even in high-resource settings.
Focused lung ultrasound, FLUS, is a point-of-care diagnostic tool that allows rapid and on-site assessment of lung abnormalities. No transportation of the patient is required thus lowering risk of spreading SAR-CoV- inside the hospital.
This study aims to explore the diagnostic value of FLUS in the COVID-19 pandemic and to explore if FLUS findings can predict risk of respiratory failure.
Eligibility Criteria
Inclusion Criteria
- Clinical suspicion of COVID-19 requiring contact to a hospital.
Exclusion Criteria
- Age less than 18 years
- Previous enrollment in this study.
Data sourced from ClinicalTrials.gov (NCT04327674). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.